Sunflower Pharmaceuticals Group Co Ltd Total Liabilities
Sunflower Pharmaceuticals Group Co Ltd total liabilities. Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has total liabilities worth CN¥1.25 Billion CNY (≈ $182.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sunflower Pharmaceuticals Group Co Ltd (002737) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
Total liabilities of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Sunflower Pharmaceuticals Group Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Sunflower Pharmaceuticals Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fnac Darty SA
PA:FNAC
|
France | €6.10 Billion |
|
FS Credit Opportunities Corp.
NYSE:FSCO
|
USA | $720.95 Million |
|
TRANSFORMERS AND RECTIFIERS INDIA
NSE:TARIL
|
India | Rs11.23 Billion |
|
Dongwon Ind
KO:006040
|
Korea | ₩3.99 Trillion |
|
Procter & Gamble Health Limited
NSE:PGHL
|
India | Rs2.75 Billion |
|
Gosuncn Technology Group Co Ltd Class A
SHE:300098
|
China | CN¥2.29 Billion |
|
Asia Optical Co Inc
TW:3019
|
Taiwan | NT$11.97 Billion |
|
Topscore Fashion
SHG:603608
|
China | CN¥279.80 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Sunflower Pharmaceuticals Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sunflower Pharmaceuticals Group Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Sunflower Pharmaceuticals Group Co Ltd Total Liabilities Ratios Explained
Sunflower Pharmaceuticals Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sunflower Pharmaceuticals Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
The table below shows the annual total liabilities of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.34 Billion ≈ $195.74 Million |
+8.23% |
| 2024-12-31 | CN¥1.24 Billion ≈ $180.85 Million |
-34.16% |
| 2023-12-31 | CN¥1.88 Billion ≈ $274.70 Million |
-27.60% |
| 2022-12-31 | CN¥2.59 Billion ≈ $379.44 Million |
+52.52% |
| 2021-12-31 | CN¥1.70 Billion ≈ $248.78 Million |
-1.31% |
| 2020-12-31 | CN¥1.72 Billion ≈ $252.07 Million |
-8.36% |
| 2019-12-31 | CN¥1.88 Billion ≈ $275.05 Million |
+15.87% |
| 2018-12-31 | CN¥1.62 Billion ≈ $237.38 Million |
+23.97% |
| 2017-12-31 | CN¥1.31 Billion ≈ $191.49 Million |
-7.80% |
| 2016-12-31 | CN¥1.42 Billion ≈ $207.68 Million |
+22.97% |
| 2015-12-31 | CN¥1.15 Billion ≈ $168.89 Million |
-20.59% |
| 2014-12-31 | CN¥1.45 Billion ≈ $212.67 Million |
+18.20% |
| 2013-12-31 | CN¥1.23 Billion ≈ $179.92 Million |
+8.23% |
| 2012-12-31 | CN¥1.14 Billion ≈ $166.24 Million |
+12.08% |
| 2011-12-31 | CN¥1.01 Billion ≈ $148.33 Million |
-- |
About Sunflower Pharmaceuticals Group Co Ltd
Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children's medicines for various therapeutic areas, including pediatrics, gynecology,… Read more